Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 3, 2013, Pages 499-504

  Song, Changhoon ^a   Kim, Kyubo ^a   Chie, Eui Kyu ^a,b   Kim, Jin Ho ^a   Jang, Jin Young ^a   Kim, Sun Whe ^a   Han, Sae Won ^a   Oh, Do Youn ^a   Im, Seock Ah ^a   Kim, Tae You ^a   Bang, Yung Jue ^a   Ha, Sung W ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN JOINT COMMITTEE ON CANCERS; CHEMORADIATION THERAPIES; CONCORDANCE INDEX; HISTOLOGIC DIFFERENTIATION; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; PERINEURAL INVASION; PROPORTIONAL HAZARDS;

BODY FLUIDS; CHEMORADIOTHERAPY; DIAGNOSIS; DISEASES; DUCTS; FORECASTING;

NOMOGRAMS;

CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; BILE DUCT CANCER; BOOTSTRAPPING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EXTRAHEPATIC BILE DUCT CANCER; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAINTENANCE CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NOMOGRAM; OVERALL SURVIVAL; PERINEURAL INVASION; PREDICTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TREATMENT DURATION; TREATMENT PLANNING; TUMOR DIFFERENTIATION;

ANALYSIS OF VARIANCE; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 84884889041     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.06.2041     Document Type: Article

References (25)

1. S.A. Khan, H.C. Thomas, and B.R. Davidson Cholangiocarcinoma Lancet 366 2005 1303 1314
2. A. Nakeeb, H.A. Pitt, and T.A. Sohn Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors Ann Surg 224 1996 463 473 discussion 473-465
3. Y. Seyama, K. Kubota, and K. Sano Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate Ann Surg 238 2003 73 83
4. M.L. DeOliveira, S.C. Cunningham, and J.L. Cameron Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution Ann Surg 245 2007 755 762
5. H.K. Gwak, W.C. Kim, and H.J. Kim Extrahepatic bile duct cancers: Surgery alone versus surgery plus postoperative radiation therapy Int J Radiat Oncol Biol Phys 78 2010 194 198
6. E.T. Shinohara, N. Mitra, and M. Guo Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas Int J Radiat Oncol Biol Phys 74 2009 1191 1198
7. T.H. Kim, S.S. Han, and S.J. Park Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer Int J Radiat Oncol Biol Phys 81 2011 e853 e859
8. M.A. Hughes, D.A. Frassica, and C.J. Yeo Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct Int J Radiat Oncol Biol Phys 68 2007 178 182
9. A.M. Horgan, E. Amir, and T. Walter Adjuvant therapy in the treatment of biliary tract cancer: A systematic review and meta-analysis J Clin Oncol 30 2012 1934 1940
10. C.D. Fuller, S.J. Wang, and M. Choi Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: A population-based analysis Cancer 115 2009 5175 5183
11. Y. Borghero, C.H. Crane, and J. Szklaruk Extrahepatic bile duct adenocarcinoma: Patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone Ann Surg Oncol 15 2008 3147 3156
12. K. Kim, E.K. Chie, and J.Y. Jang Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: A long-term single center experience Am J Clin Oncol 35 2012 136 140
13. Memorial Sloan-Kettering Cancer Center. Prediction tools. Available at: http://nomograms.org. Accessed July 19, 2013.
14. Cleveland Clinic Lerner Research Institute. Risk calculators http://www.lerner.ccf.org/qhs/risk-calculator. Accessed July 19, 2013.
15. Adjuvant! Available at: http://www.adjuvantonline.com/index.jsp. Accessed July 19, 2013.
16. M.W. Kattan Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: Preoperative application in prostate cancer Curr Opin Urol 13 2003 111 116
17. M.R. Weiser, R.G. Landmann, and M.W. Kattan Individualized prediction of colon cancer recurrence using a nomogram J Clin Oncol 26 2008 380 385
18. T. Hoang, R. Xu, and J.H. Schiller Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data J Clin Oncol 23 2005 175 183
19. N.A. van der Gaag, J.J. Kloek, and J.K. de Bakker Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma Ann Oncol 23 2012 2642 2649
20. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Cancer Staging Manual 6th ed. 2002 Springer New York
21. K. Kim, E.K. Chie, and J.Y. Jang Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer Int J Radiat Oncol Biol Phys 84 2012 81 87
22. H. Akaike A new look at the statistical model identification IEEE Trans Autom Control 19 1974 716 723
23. A. Iasonos, D. Schrag, and G.V. Raj How to build and interpret a nomogram for cancer prognosis J Clin Oncol 26 2008 1364 1370
24. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
25. S.B. Edge, D.R. Byrd, and C.C. Compton AJCC Cancer Staging Manual 7th ed. 2010 Springer New York